Trust the proven solution for syndromic meningitis testing.
Stay the most aligned with WHO Guidelines.
Key recommendations from the WHO’s guidelines for meningitis include:
FAST IDENTIFICATION
of causative pathogens within hours, not days
MOLECULAR DIAGNOSTIC METHODS
such as PCR testing are strongly recommended
MULTIPLEX PCR SYSTEMS
are highlighted
The BIOFIRE FILMARRAY ME Panel served as the foundation for the recommendations for molecular testing in the guidelines. With 190+ publications, it is the most-studied syndromic panel for meningitis on the market.
Download our Diagnostic Guideline Summary to learn more about how the BIOFIRE FILMARRAY ME Panel can help you align your institution with the new WHO Guidelines on Meningitis.
Accurate Answers, Fast
Every minute counts in central nervous system infections. Because viral and bacterial meningitis share symptoms like fever, headache, photophobia, and neck stiffness, diagnosis based on clinical presentation alone is challenging.1,2
Timely detection enables the initiation of specific therapy, which may lead to improved patient outcomes.3-6
WHY HERPES VIRUS DETECTION MATTERS
Leaving out key targets can create gaps in delivery of care.
While most common viral infections do not require specific therapy, this is not the case with select herpes viruses, which require antiviral treatment for the best prognosis. The BIOFIRE FILMARRAY ME Panel is the only FDA-Cleared multiplex molecular panel to include 5 key herpes virus targets* (including CMV, HSV-1, HSV-2, VZV and HHV-6) to support early clinical decisions and improve patient outcomes.
IMV SERVICETRAK 2024 AWARDS
Your Trusted Partner for
Syndromic Testing
bioMérieux offers seven comprehensive panels that are US FDA-cleared and/or CE-marked, designed to detect over 175+ of the most common pathogens and antimicrobial resistance genes.
Ready for a comprehensive approach to meningitis testing?
Fill out the form below to download a free diagnostic guideline summary of the 2025 WHO meningitis guidelines.